Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.13
-0.48 (-5.57%)
Mar 25, 2025, 4:00 PM EST - Market closed
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$612,558
Profits / Employee
-$462,558
Market Cap
559.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ARVN News
- 14 days ago - Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial - Benzinga
- 14 days ago - Arvinas-Pfizer's breast cancer treatment meets main goal in late-stage study - Reuters
- 14 days ago - Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial - GlobeNewsWire
- 21 days ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - These Analysts Revise Their Forecasts On Arvinas After Q4 Results - Benzinga
- 6 weeks ago - Arvinas, Inc. (ARVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025 - GlobeNewsWire